Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Tissue Antigens ; 65(5): 488-92, 2005 May.
Article in English | MEDLINE | ID: mdl-15853905

ABSTRACT

A new human leukocyte antigen (HLA)-B allele was found during routine typing of samples for a German unrelated bone marrow donor registry, the "Aktion Knochenmarkspende Bayern". After first interpretation of data of two independent low-resolution sequence-specific oligonucleotide typing tests, a B*51 variant was suggested. Further analysis via sequence-based typing identified the sequence as new B*52 allele. This new allele officially assigned as B*5206 differs from HLA-B*520102 by one nucleotide exchange in exon 2. The mutation is located at nucleotide position 274, at which a cytosine is substituted by a thymine leading to an amino acid change at protein position 67 from serine (TCC) to phenylalanine (TTC).


Subject(s)
Genes, MHC Class I , HLA-B Antigens/genetics , Polymorphism, Single Nucleotide , Alleles , Amino Acid Substitution , Base Sequence , Genotype , Germany , HLA-B Antigens/chemistry , HLA-B Antigens/isolation & purification , HLA-B52 Antigen , Humans , Molecular Sequence Data , Polymerase Chain Reaction/methods , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Nucleic Acid
2.
Leuk Lymphoma ; 25(3-4): 217-24, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9168432

ABSTRACT

Intensity of pretransplant conditioning has been closely correlated with regimen related toxicity in patients receiving allogeneic bone marrow transplantation (BMT). In this review, we summarize evidence for a direct link between inflammatory reactions induced by irradiation and cytotoxic treatment and occurrence of acute graft-versus-host disease (GvHD) as well as endothelial complications: In our studies, de novo release of TNFalpha during conditioning was associated with an increased risk of severe GvHD and mortality following BMT, whereas increased spontaneous production of IL-10, an endogenous TNF-antagonist, prior to conditioning protected from these complications. Immunogenetic differences in cytokine regulation and costimulation by endotoxin proved to be important cofactors determining the extent of inflammatory cytokine release in individual patients. Pathophysiological relevance of these findings seems to be confirmed by experimental as well as first clinical trials using TNF-antibodies and related antagonists during pretransplant conditioning. Preclinical experiments suggest additional, cytokine independent inflammatory reactions induced by irradiation such as expression of ICAM-1 and endothelial cell apoptosis. Although the exact impact of these findings on pathophysiology of BMT related complications needs further clarification by future studies, conditioning related inflammation as a first crucial step in induction of GvHD and complications has to be considered when designing new protocols for preparation of patients for allogeneic BMT.


Subject(s)
Bone Marrow Transplantation/adverse effects , Cytokines/physiology , Graft vs Host Disease/prevention & control , Graft vs Host Disease/physiopathology , Inflammation , Transplantation Conditioning/adverse effects , Animals , Antibodies, Monoclonal/therapeutic use , Bone Marrow Transplantation/methods , Clinical Trials as Topic , Cytokines/antagonists & inhibitors , Graft vs Host Disease/immunology , Humans , Tumor Necrosis Factor-alpha/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...